Trump Tests Negative for COVID-19


After he and the First Lady were diagnosed with COVID-19 on October 2nd, U.S. President Donald Trump has reportedly tested negative for the virus.

The news comes from the President’s physician, Sean P. Conley, who sent an update to Donald Trump’s assistant and White House press secretary, Kayleigh McEnany, stating that:

“In response to your inquiry regarding the President’s most recent COVID-19 tests, I can share with you that he has tested NEGATIVE, on consecutive days, using the Abbott BinaxNOW antigen card.”

the document goes on to state that:

“it is important to note that this test was not used in isolation for the determination of the President’s current negative status. Repeatedly negative antigen tests, taken in context with additional clinical and laboratory data, including viral load, subgenomic RNA, and PCR cycle threshold measurements, as well as ongoing assessment of viral culture data, all indicate a lack of detectable viral replication. This comprehensive data, in concert with the CDC’s guidelines for removal of transmission-based precautions, have informed out medical team’s assessment that the PResident is not infectious to others.”

The news comes after headlines which pointed out that while Trump stated he no longer had COVID-19 symptoms, he hadn’t specifically stated he had tested negative.

Now, it is confirmed that the current U.S. President in fact no longer has COVID-19, however, the second Presidential debate between Donald Trump and Democratic Frontrunner Joe Biden that was slated to occur on October 15th has already been cancelled due to Trump’s condition.

Now, President Donald Trump and Joe Biden will only have one final debate, in addition to their first debate, meaning that the duo will only verbally spar twice instead of the usual three Presidential debates.

About Louis O'Neill 76 Articles
Having received a bachelor’s degree in journalism from Macquarie University, Louis’ writing spans across cultural, social and political issues. Louis' work has been shared in Benzinga, FinFeed, The Green Fund, The Startup, The Quarry Journal, Independent Australia and Online Opinion.